Andre Kelly

ORCID: 0009-0000-6104-6107
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Immune Cell Function and Interaction
  • CAR-T cell therapy research
  • T-cell and B-cell Immunology
  • Immunotherapy and Immune Responses
  • Virus-based gene therapy research
  • Viral Infectious Diseases and Gene Expression in Insects
  • Pancreatic function and diabetes
  • Diet and metabolism studies
  • CRISPR and Genetic Engineering
  • Protein Degradation and Inhibitors
  • Diet, Metabolism, and Disease

University of Pennsylvania
2023-2024

Chimeric antigen receptor (CAR) T cell dysfunction is a major barrier to achieving lasting remission in hematologic cancers, especially chronic lymphocytic leukemia (CLL). We have shown previously that Δ133p53α, an endogenous isoform of the human TP53 gene, decreases expression with age cells, and reconstitution Δ133p53α poorly functional cells can rescue proliferation [A. M. Mondal

10.1073/pnas.2317735121 article EN cc-by-nc-nd Proceedings of the National Academy of Sciences 2024-02-26

Natural killer (NK) cells are frequently expanded for the clinic using irradiated, engineered K562 feeder expressing a core transgene set of membrane-bound (mb) IL15 and/or mbIL21 together with 41BBL. Prior comparisons mbIL15 to NK expansion lack key attributes resulting cells, including their high-dimensional phenotype, polyfunctionality, breadth and potency cytotoxicity, cellular metabolism, activity in xenograft tumor models. Moreover, despite multiple rounds stimulation, studies...

10.1158/2326-6066.cir-23-0151 article EN cc-by-nc-nd Cancer Immunology Research 2023-08-30

Abstract Patients with multiple myeloma (MM) treated B-cell maturation antigen (BCMA)-specific chimeric receptor (CAR) T cells usually relapse BCMA+ disease, indicative of CAR T-cell suppression. CD200 is an immune checkpoint that overexpressed on aberrant plasma (aPCs) in MM and independent negative prognostic factor for survival. However, not present cell lines, a potential limitation current preclinical models. We engineered lines to express at levels equivalent those found aPCs show...

10.1182/blood.2022018658 article EN cc-by-nc-nd Blood 2023-08-24

Early expansion and long-term persistence predict efficacy of chimeric antigen receptor T cells (CARTs)

10.1038/s41586-024-07862-7 article EN cc-by-nc-nd Nature 2024-08-28

<h3>Background</h3> The success of CAR T-cell immunotherapy depends on the differentiation status and metabolic fitness product. In current CART manufacturing protocols, activation leads to irreversible differentiation. Our recent work showed that nonactivated T-cells can be generated within 24 hours, eliminating need for or <i>ex vivo</i> expansion. We assert this process retains maximal Interleukin 18 (IL-18) is a proinflammatory cytokine regulates adoptively transferred T-cells, IL-18...

10.1136/jitc-2023-sitc2023.0442-b article EN cc-by-nc 2023-10-31

Activated T cells undergo a metabolic shift to aerobic glycolysis support the energetic demands of proliferation, differentiation, and cytolytic function. Transmembrane glucose flux is facilitated by transporters (GLUT) that play vital role in cell reprogramming anti-tumour GLUT isoforms are regulated at level expression subcellular distribution. GLUTs also display preferential selectivity for carbohydrate macronutrients including glucose, galactose, fructose. GLUT5, which selectively...

10.21203/rs.3.rs-4342820/v1 preprint EN cc-by Research Square (Research Square) 2024-05-07

&lt;div&gt;Abstract&lt;p&gt;Natural killer (NK) cells are frequently expanded for the clinic using irradiated, engineered K562 feeder expressing a core transgene set of membrane-bound (mb) IL15 and/or mbIL21 together with 41BBL. Prior comparisons mbIL15 to NK expansion lack key attributes resulting cells, including their high-dimensional phenotype, polyfunctionality, breadth and potency cytotoxicity, cellular metabolism, activity in xenograft tumor models. Moreover, despite multiple rounds...

10.1158/2326-6066.c.6908397.v1 preprint EN 2023-11-01

&lt;div&gt;Abstract&lt;p&gt;Natural killer (NK) cells are frequently expanded for the clinic using irradiated, engineered K562 feeder expressing a core transgene set of membrane-bound (mb) IL15 and/or mbIL21 together with 41BBL. Prior comparisons mbIL15 to NK expansion lack key attributes resulting cells, including their high-dimensional phenotype, polyfunctionality, breadth and potency cytotoxicity, cellular metabolism, activity in xenograft tumor models. Moreover, despite multiple rounds...

10.1158/2326-6066.c.6908397 preprint EN 2023-11-01
Coming Soon ...